(Stroke. 1998;29:2-3.)
© 1998 American Heart Association, Inc.
Are There Differences in Vascular Disease Between Ethnic and Racial Groups?
Askiel Bruno, MD
From the Cerebrovascular Program, Department of Neurology, Indiana
University School of Medicine, Indianapolis.
Correspondence to Askiel Bruno, MD, Neurology Department, 541 Clinical Dr, Room 365, Indiana University School of Medicine, Indianapolis, IN 46202-5111.
Key Words: genetics racial differences stroke ethnic groups vascular diseases
The study of disease
differences between ethnic and racial groups is complicated by the
genetic, environmental, and cultural heterogeneity
within each group. Despite these complications, the study of
well-defined groups of people can yield medical information useful to
improve health in these groups. For example, moyamoya disease has a
predilection for Japanese people, the incidence of stroke is higher in
blacks than in whites,1 and occlusive cerebrovascular
lesions are more likely to be intracranial in blacks than
whites.2 3 4 This information can be used to optimize risk
factor screening and management, acute stroke treatment, and secondary
stroke prevention in the various ethnic and racial groups.
Relatively little is known about cerebrovascular disease in
Hispanics and Native Americans in the southwestern United States.
Hispanics constitute
9.0% of the US population according to the
1990 US census, and a large majority of them live in the southwestern
United States. The ancestors of the Hispanics in the southwestern
United States are mainly the settlers and conquerors who came from
Spain starting in the 16th century. Since their arrival in the southern
part of North America, there has been cultural and genetic interaction
between the Spanish and the various Native American tribes living in
this region. The Hispanics who relatively recently immigrated from
Mexico to the southwestern United States have a similar ancestry.
Differences in vascular risks have been measured between US Hispanics
and non-Hispanic whites. US Hispanics appear to have a lower prevalence
and severity of arterial hypertension and lower levels of
serum cholesterol . . . [Full Text of this Article]
This article has been cited by other articles:

|
 |

|
 |
 
S. Yang, A. Bhardwaj, J. Cheng, N. J. Alkayed, P. D. Hurn, and J. R. Kirsch
Sigma Receptor Agonists Provide Neuroprotection In Vitro by Preserving bcl-2
Anesth. Analg.,
May 1, 2007;
104(5):
1179 - 1184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Stansbury, H. Jia, L. S. Williams, W. B. Vogel, and P. W. Duncan
Ethnic Disparities in Stroke: Epidemiology, Acute Care, and Postacute Outcomes
Stroke,
February 1, 2005;
36(2):
374 - 386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W.M. Raaymakers, G. J.E. Rinkel, and L. M.P. Ramos
Initial and follow-up screening for aneurysms in families with familial subarachnoid hemorrhage
Neurology,
October 1, 1998;
51(4):
1125 - 1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. DeGraba
The role of inflammation after acute stroke: Utility of pursuing anti-adhesion molecule therapy
Neurology,
September 1, 1998;
51(3_Suppl_3):
S62 - S68.
[Abstract]
[Full Text]
[PDF]
|
 |
|